ERBB2 and neoplasm: Immunohistochemistry demonstrated uniform staining of HER2 throughout the tumors (Fig. 1a, right), and the distribution of HER2 expression matched the extent of the tumor, as revealed by H&E staining (Fig. 1a, left) and T1-weighted MRI (Fig. 1b).